Mesabi Trust (MSB) Options Positioning, Max Pain & Unusual Sweeps

Per the Roarable RQD rating, MSB scores 43 out of 100, earning a D- grade and the verdict label "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are: Fundamental Cash Engine at 10 / 20 (ROIC 0%; FCF yield 0%), Whale 13F Flow at 3 / 20 (institutional accumulation and options positioning), Insider Conviction at 9 / 20 (SEC Form 4 and Congressional PTR cluster flow), Macro Regime Fit at 8 / 20 (Beta 1.0; sector sensitivity), and Forensic Balance Sheet at 13 / 20 (Altman Z 2.5; Piotroski F 6/9; Debt/Equity 0.5). The weakest pillars are Whale 13F Flow and Macro Regime Fit, while Forensic Balance Sheet is the relative strength. For a prospective investor evaluating the stock today, the rating implies that the cash-generation pillar is scored low because the current-period ROIC and FCF yield are both recorded at 0%, which limits the upside case that rests on earnings power. The forensic metrics (Altman Z 2.5, Piotroski F 6/9, Debt/Equity 0.5) are the most supportive part of the profile, suggesting a balance sheet that is not the primary source of concern, though the rating's verdict characterizes it as vulnerable. Valuation tradeoffs cannot be fully assessed because P/E, Forward P/E, and EV/EBITDA are not available in source data; the investor is therefore left without standard multiple-based comparisons. Second-order, a low flow score combined with a low insider score signals limited observed conviction from informed participants in the source data.

Per the SEC financials, FY 2025 reports zero revenue and zero net income, while FY 2024 and FY 2023 show revenue of $98.6M and $22.9M and net income of $93.3M and $19.0M respectively. Per the market data, gross, operating, and net margins are each recorded at 0%, and ROIC is 0%. Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 6/9, and Debt/Equity is 0.5. The source data does not reconcile the zero-value FY 2025 entries with the positive FY 2024 and FY 2023 figures, and operating income is reported as $0.0M for all periods.

Per the recent news and catalysts section, multiple headlines reference a "Mesabi Trust Announcement of No Distribution" and "Mesabi Trust Announces Not Declares Distribution for This Quarter," both flagged YELLOW. The most significant item is a TradingView headline, flagged RED under RISK WATCH, reporting that trustees declared no distribution for Nov 2026 after a sharp drop in royalty receipts. Other items include Yahoo! Finance Canada, TradingView, and Stock Traders Daily reports on market action and institutional positioning, all flagged YELLOW under MARKET WIRE. The butterfly supply-chain graph reports sector "Materials," industry "Precious Metals," supply chain "NONE," with no butterfly links and no proprietary signals.

Per the Butterfly Supply-Chain Graph, no upstream or downstream supply-chain links are recorded, and no proprietary signals are present. Sector correlation data beyond the Materials / Precious Metals classification is not available in source data. The source data therefore does not identify specific 2nd-order bottlenecks. An investor should note that the RISK WATCH headline regarding a sharp drop in royalty receipts points to revenue sensitivity, but the source data does not link this to any named supplier, customer, or peer.

• What explains the FY 2025 zero-value revenue and net income entries relative to positive FY 2024 and FY 2023 figures, and are these reporting artifacts or actual results?
• What is the cause and magnitude of the reported "sharp drop in royalty receipts," and how does it relate to the declared non-distribution?
• Why are P/E, Forward P/E, EV/EBITDA, and EPS unavailable, and what would a standard multiple-based valuation show?
• What do the Whale 13F and Insider Conviction pillars reflect at the individual-filing level, given that the holders section is empty?
• Does the Forensic Balance Sheet score hold when cash and debt balances, currently recorded as N/A, become available?